|
CCDC77 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.94555524205498E-13 |
| Normal-vs-Stage2 |
3.30899996292544E-09 |
| Normal-vs-Stage3 |
1.75139902580668E-11 |
| Normal-vs-Stage4 |
1.72599712300325E-11 |
| Stage1-vs-Stage2 |
1.282360E-01 |
| Stage1-vs-Stage3 |
3.728000E-01 |
| Stage1-vs-Stage4 |
5.359900E-02 |
| Stage2-vs-Stage3 |
4.315600E-01 |
| Stage2-vs-Stage4 |
8.043400E-01 |
| Stage3-vs-Stage4 |
2.450800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40918396343659E-14 |
| Normal-vs-AfricanAmerican |
1.194300E-04 |
| Normal-vs-Asian |
6.16310000034481E-07 |
| Caucasian-vs-AfricanAmerican |
6.190600E-01 |
| Caucasian-vs-Asian |
5.638200E-01 |
| AfricanAmerican-vs-Asian |
9.555000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18840048912716E-10 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
3.259800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.22764079089211E-12 |
| Normal-vs-Age(41-60Yrs) |
2.37698749572246E-13 |
| Normal-vs-Age(61-80Yrs) |
1.19080301175245E-11 |
| Normal-vs-Age(81-100Yrs) |
3.895700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.941400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.513050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.018200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.568600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.723000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.796000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.394240E-02 |
| Classical-VS-Follicular |
4.928300E-02 |
| Classical-VS-Other |
8.899800E-01 |
| Classical-VS-Normal |
1.25789999527726E-08 |
| Tall-VS-Follicular |
3.541000E-01 |
| Tall-VS-Other |
5.591600E-01 |
| Tall-VS-Normal |
1.10339959391581E-10 |
| Follicular-VS-Other |
6.788000E-01 |
| Follicular-VS-Normal |
1.59779967034979E-10 |
| Other-VS-Normal |
1.611830E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.87703235971549E-13 |
| Normal-vs-N1 |
1.15040199588634E-11 |
| N0-vs-N1 |
9.429700E-02 |
|
|
